DEVELOPMENT OF PPAR-γ RECEPTOR AGONISTS AS THERAPEUTIC AGENTS FOR DIABETES
The peroxisome proliferator-activated receptors (PPARs) are the transcriptional regulators of glucose, lipids and cholesterol metabolisms. It has been established that PPAR-γ is the receptor for thiazolidinediones (TZDs) class of type II anti-diabetic drugs. These compounds act as agonists of PPAR-γ...
Main Author: | |
---|---|
Format: | Others |
Published: |
VCU Scholars Compass
2009
|
Subjects: | |
Online Access: | http://scholarscompass.vcu.edu/etd/1881 http://scholarscompass.vcu.edu/cgi/viewcontent.cgi?article=2880&context=etd |